Skip to main content
OpenTrials
Completed

NCT Number: NCT03821103

Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments

This study seeks to test standard and behavioral economic-enhanced training strategies to bolster first-time Emergency Department-initiated buprenorphine-naloxone administration among Emergency Department providers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Opioid Use

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pennsylvania Health System

Philadelphia, Pennsylvania, 19104, United States

About this study

Philadelphia is experiencing a significant opioid crisis. Through this novel pilot study, critical training about opioid use disorder and medication-assisted treatment with buprenorphine-naloxone will be provided to emergency providers and changes in clinical practice will be incentivized in order to optimize treatment engagement for patients with opioid use disorder in the Emergency Department.

Participants will be invited to participate in a brief in-person training session, will receive a pre- and post-session knowledge and attitude assessment, and will be invited to self-report first-time buprenorphine-naloxone Emergency Department administration within the 3 month study period.

Participants will be randomized to one of two arms: standard training arm and behavioral economic enhanced arm. The standard training arm will receive the aforementioned intervention. The behavioral economic enhanced arm will additionally receive an opt-out invitation, loss-framed incentivization, and weekly tailored text message-based reminders.

Endpoints of interest include retained knowledge and change in provider attitudes regarding Emergency department buprenorphine-naloxone administration and treatment following training and again at 3 months, and first-time Emergency department administration of buprenorphine-naloxone.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Residents and Advanced Practice Providers and attending clinicians working in emergency departments in Pennsylvania.

Exclusion criteria

-

Treatment and study plan

Training

Behavioral

The training includes of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department (ED) administration within 3 month study period

Behavioral economic enhanced arm

Behavioral

Behavioral economic enhancement includes an opt-out invitation, loss-framed incentivization, weekly tailored text based reminders

Primary outcomes

  1. Change in Emergency Department initiated buprenorphine-naloxone treatment

    Time frame: One year

    Measuring number of providers who have initiated at least one first dose of buprenorphine-naloxone

Secondary outcomes

  1. Training Attendance

    Time frame: First week

    Measure the number of clinicians who attend the training with the incentive.

  2. Change in attitude about buprenorphine-naloxone Questionaire

    Time frame: Three months

    The scale is not a validated tool. It is a construct to measure attitudes about buprenorphine-naloxone.

    It is a Likert scale 1-5, 1 being strongly disagree and 5 being strongly agree. Higher values signify more favorable outcomes.

Other outcomes

  1. Retained knowledge of buprenorphine-naloxone treatment Questionaire

    Time frame: Three months

    Compare retention of knowledge and assessment from before and after the training in the two arms.The scale is not a validated tool. It is a construct of questions to measure retained knowledge about buprenorphine-naloxone initiation.

    The scale is a percentage of questions answered correctly. Minimum score is 0% and maximum score is 100%.

    Higher values signify more favorable outcomes.

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • American College of Medical Toxicology
  • Blue Cross Blue Shield

Registry information

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jan 29, 2019
Registry last updated
Mar 17, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.